Social contagion in new product trial and repeat

Raghuram Iyengar, Christophe Van den Bulte, Jae Young Lee

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

The notion of peer influence in new product adoption or trial is well accepted. We propose that peer influence may affect repeat behavior as well, though the process and source of influence are likely to differ between trial and repeat. Our analysis of the acceptance of a risky prescription drug by physicians provides three novel findings. First, there is evidence of contagion not only in trial but also in repeat. Second, who is most influential varies across stages. Physicians with high centrality in the discussion and referral network and with high prescription volume are influential in trial but not repeat. In contrast, immediate colleagues, few of whom are nominated as a discussion or referral partner, are influential in both trial and repeat. Third, who is most influenceable also varies across stages. For trial, it is physicians who do not consider themselves to be opinion leaders, whereas for repeat, it is those located towards the middle of the status distribution as measured by network centrality. The pattern of results is consistent with informational social influence reducing risk in trial and normative social influence increasing conformity in repeat.

Original languageEnglish
Pages (from-to)408-429
Number of pages22
JournalMarketing Science
Volume34
Issue number3
DOIs
Publication statusPublished - 2015 Jan 1

Fingerprint

Product trial
Social contagion
New products
Physicians
Peer influence
Social influence
Referral
Prescription
New product adoption
Centrality
Prescription drugs
Opinion leaders
Conformity
Contagion
Network centrality
Acceptance

All Science Journal Classification (ASJC) codes

  • Business and International Management
  • Marketing

Cite this

Iyengar, Raghuram ; Van den Bulte, Christophe ; Lee, Jae Young. / Social contagion in new product trial and repeat. In: Marketing Science. 2015 ; Vol. 34, No. 3. pp. 408-429.
@article{36081d12a114482086a6c737d82341eb,
title = "Social contagion in new product trial and repeat",
abstract = "The notion of peer influence in new product adoption or trial is well accepted. We propose that peer influence may affect repeat behavior as well, though the process and source of influence are likely to differ between trial and repeat. Our analysis of the acceptance of a risky prescription drug by physicians provides three novel findings. First, there is evidence of contagion not only in trial but also in repeat. Second, who is most influential varies across stages. Physicians with high centrality in the discussion and referral network and with high prescription volume are influential in trial but not repeat. In contrast, immediate colleagues, few of whom are nominated as a discussion or referral partner, are influential in both trial and repeat. Third, who is most influenceable also varies across stages. For trial, it is physicians who do not consider themselves to be opinion leaders, whereas for repeat, it is those located towards the middle of the status distribution as measured by network centrality. The pattern of results is consistent with informational social influence reducing risk in trial and normative social influence increasing conformity in repeat.",
author = "Raghuram Iyengar and {Van den Bulte}, Christophe and Lee, {Jae Young}",
year = "2015",
month = "1",
day = "1",
doi = "10.1287/mksc.2014.0888",
language = "English",
volume = "34",
pages = "408--429",
journal = "Marketing Science",
issn = "0732-2399",
publisher = "INFORMS Inst.for Operations Res.and the Management Sciences",
number = "3",

}

Social contagion in new product trial and repeat. / Iyengar, Raghuram; Van den Bulte, Christophe; Lee, Jae Young.

In: Marketing Science, Vol. 34, No. 3, 01.01.2015, p. 408-429.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Social contagion in new product trial and repeat

AU - Iyengar, Raghuram

AU - Van den Bulte, Christophe

AU - Lee, Jae Young

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The notion of peer influence in new product adoption or trial is well accepted. We propose that peer influence may affect repeat behavior as well, though the process and source of influence are likely to differ between trial and repeat. Our analysis of the acceptance of a risky prescription drug by physicians provides three novel findings. First, there is evidence of contagion not only in trial but also in repeat. Second, who is most influential varies across stages. Physicians with high centrality in the discussion and referral network and with high prescription volume are influential in trial but not repeat. In contrast, immediate colleagues, few of whom are nominated as a discussion or referral partner, are influential in both trial and repeat. Third, who is most influenceable also varies across stages. For trial, it is physicians who do not consider themselves to be opinion leaders, whereas for repeat, it is those located towards the middle of the status distribution as measured by network centrality. The pattern of results is consistent with informational social influence reducing risk in trial and normative social influence increasing conformity in repeat.

AB - The notion of peer influence in new product adoption or trial is well accepted. We propose that peer influence may affect repeat behavior as well, though the process and source of influence are likely to differ between trial and repeat. Our analysis of the acceptance of a risky prescription drug by physicians provides three novel findings. First, there is evidence of contagion not only in trial but also in repeat. Second, who is most influential varies across stages. Physicians with high centrality in the discussion and referral network and with high prescription volume are influential in trial but not repeat. In contrast, immediate colleagues, few of whom are nominated as a discussion or referral partner, are influential in both trial and repeat. Third, who is most influenceable also varies across stages. For trial, it is physicians who do not consider themselves to be opinion leaders, whereas for repeat, it is those located towards the middle of the status distribution as measured by network centrality. The pattern of results is consistent with informational social influence reducing risk in trial and normative social influence increasing conformity in repeat.

UR - http://www.scopus.com/inward/record.url?scp=84929413750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929413750&partnerID=8YFLogxK

U2 - 10.1287/mksc.2014.0888

DO - 10.1287/mksc.2014.0888

M3 - Article

AN - SCOPUS:84929413750

VL - 34

SP - 408

EP - 429

JO - Marketing Science

JF - Marketing Science

SN - 0732-2399

IS - 3

ER -